Lana Pine is the editor of HCPLive Rheumatology. She is an experienced editor and technical writer with a demonstrated history of working in the banking and publishing industries. In her free time, she enjoys cooking, yoga, listening to podcasts, and drawing. She can be reached via email at LPine@mjhlifesciences.com.
Telemedicine Reviews Varied Among Patients With Psoriatic Arthritis
February 28th 2022“This dramatic change in healthcare delivery led to significant challenges amongst healthcare management teams, healthcare professionals as well as patients, especially during the early phases of implementation," investigators stated.
Read More
Overdrive Podcast: Efficacy of Guselkumab for Treating Psoriatic Arthritis
February 23rd 2022On this month's episode of Overdrive, Rheumatology Network interviewed Terence Rooney, MD, to discuss the findings of a network meta-analysis that examined the efficacy of guselkumab (TREMFYA) for skin clearance and joint improvements in patients with psoriatic arthritis.
Read More
Guselkumab Ranks Highest for Skin Clearance, Positive Joint Efficacy in PsA
February 7th 2022Rheumatology Network interviewed Terence Rooney, MD, to discuss the findings of a Network Meta-Analysis that examined the efficacy of guselkumab (TREMFYA) for skin clearance and joint improvements in patients with psoriatic arthritis.
Read More
PsA Does Not Increase Risk of Venous Thromboembolic Events
February 7th 2022Given the recent concerns regarding venous thromboembolic events in patients with rheumatic disease and pre-existing cardiovascular risk factors being treated with tofacitinib, investigators addressed the occurrence of VTE in patients with PsA.
Read More
American College of Rheumatology Revises COVID-19 Vaccine Clinical Guidance, Supports 4th Dose
February 4th 2022The American College of Rheumatology (ACR) has published guidance regarding COVID-19 vaccination for patients with rheumatic diseases, with emphasis placed on supplemental and booster doses for patients with rheumatic disease.
Read More
Xavier Mariette, MD, PhD: Antibody Response in Rituximab-Treated Patients After COVID-19 Vaccination
February 3rd 2022Xavier Mariette, MD, PhD, explains the results of his study examining how rituximab impacts B-cell and T-cell response to COVID-19 vaccine in patients with rheumatic disease.
Read More
Improvements in Telehealth May Better Treat Pediatric Rheumatic Diseases
February 2nd 2022As telehealth is an emerging and rapidly changing form of pediatric rheumatology care, engaging patients, caregivers, and rheumatologists will help streamline care to improve satisfaction and overall experience.
Read More
Polygenic Risk Score May Predict Radiographic Progression in RA
February 1st 2022"Prevention of severe radiographic progression in a certain percentage of patients remains a challenge because of inadequate treatment response or adverse events associated with therapeutic agents," investigators stated.
Read More
Farzin Khosrow-Khavar, MSc, PhD: Tofacitinib and Cardiovascular Risk in RA
January 31st 2022Farzin Khosrow-Khavar, MSc, PhD, discusses his study “Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study.”
Read More